279 related articles for article (PubMed ID: 33252452)
1. Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache.
Guo Z; Czerpaniak K; Zhang J; Cao YQ
Pain; 2021 May; 162(5):1483-1499. PubMed ID: 33252452
[TBL] [Abstract][Full Text] [Related]
2. Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization.
Ryu S; Liu X; Guo T; Guo Z; Zhang J; Cao YQ
Brain; 2023 Oct; 146(10):4274-4291. PubMed ID: 37284790
[TBL] [Abstract][Full Text] [Related]
3. Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans.
Frederiksen SD; Warfvinge K; Ohlsson L; Edvinsson L
Neuroscience; 2018 Nov; 393():319-332. PubMed ID: 30336190
[TBL] [Abstract][Full Text] [Related]
4. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
5. Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine.
Wu H; Dong Z; Liu Y; Zhang Q; Zhang M; Hu G; Yu S; Han X
Mol Pain; 2023; 19():17448069231152129. PubMed ID: 36604785
[No Abstract] [Full Text] [Related]
6. PACAP Induces Light Aversion in Mice by an Inheritable Mechanism Independent of CGRP.
Kuburas A; Mason BN; Hing B; Wattiez AS; Reis AS; Sowers LP; Moldovan Loomis C; Garcia-Martinez LF; Russo AF
J Neurosci; 2021 May; 41(21):4697-4715. PubMed ID: 33846231
[TBL] [Abstract][Full Text] [Related]
7. Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system.
Edvinsson JCA; Grell AS; Warfvinge K; Sheykhzade M; Edvinsson L; Haanes KA
Cephalalgia; 2020 Oct; 40(12):1296-1309. PubMed ID: 32486909
[TBL] [Abstract][Full Text] [Related]
8. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.
Eftekhari S; Salvatore CA; Johansson S; Chen TB; Zeng Z; Edvinsson L
Brain Res; 2015 Mar; 1600():93-109. PubMed ID: 25463029
[TBL] [Abstract][Full Text] [Related]
9. From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment.
Tanaka M; Szabó Á; Körtési T; Szok D; Tajti J; Vécsei L
Cells; 2023 Nov; 12(22):. PubMed ID: 37998384
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
11. Shared and independent roles of CGRP and PACAP in migraine pathophysiology.
Kuburas A; Russo AF
J Headache Pain; 2023 Apr; 24(1):34. PubMed ID: 37009867
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in migraine treatment.
Dominguez-Moreno R; Do TP; Ashina M
Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):225-231. PubMed ID: 35066541
[TBL] [Abstract][Full Text] [Related]
13. Future targets for migraine treatment beyond CGRP.
Al-Hassany L; Boucherie DM; Creeney H; van Drie RWA; Farham F; Favaretto S; Gollion C; Grangeon L; Lyons H; Marschollek K; Onan D; Pensato U; Stanyer E; Waliszewska-Prosół M; Wiels W; Chen HZ; Amin FM;
J Headache Pain; 2023 Jun; 24(1):76. PubMed ID: 37370051
[TBL] [Abstract][Full Text] [Related]
14. Role of PACAP in migraine: An alternative to CGRP?
Guo S; Jansen-Olesen I; Olesen J; Christensen SL
Neurobiol Dis; 2023 Jan; 176():105946. PubMed ID: 36481434
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors α, β and GPER in the CNS and trigeminal system - molecular and functional aspects.
Warfvinge K; Krause DN; Maddahi A; Edvinsson JCA; Edvinsson L; Haanes KA
J Headache Pain; 2020 Nov; 21(1):131. PubMed ID: 33167864
[TBL] [Abstract][Full Text] [Related]
16. PACAP and its role in primary headaches.
Edvinsson L; Tajti J; Szalárdy L; Vécsei L
J Headache Pain; 2018 Mar; 19(1):21. PubMed ID: 29523978
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin/PAC
Rees TA; Labastida-Ramírez A; Rubio-Beltrán E
Trends Pharmacol Sci; 2023 Oct; 44(10):651-663. PubMed ID: 37543479
[TBL] [Abstract][Full Text] [Related]
18. The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?
Ernstsen C; Christensen SL; Rasmussen RH; Nielsen BS; Jansen-Olesen I; Olesen J; Kristensen DM
Brain; 2022 Jul; 145(7):2450-2460. PubMed ID: 35136961
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model.
Zhang L; Zhou Y; Wang Y; Yang L; Wang Y; Shan Z; Liang J; Xiao Z
Cephalalgia; 2023 Apr; 43(4):3331024231163131. PubMed ID: 36946245
[TBL] [Abstract][Full Text] [Related]
20. PACAP-38 Induces Transcriptomic Changes in Rat Trigeminal Ganglion Cells Related to Neuroinflammation and Altered Mitochondrial Function Presumably via PAC1/VPAC2 Receptor-Independent Mechanism.
Takács-Lovász K; Kun J; Aczél T; Urbán P; Gyenesei A; Bölcskei K; Szőke É; Helyes Z
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
